Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (8)

« Back to Publications

Early deficits in an in vitro striatal microcircuit model carrying the Parkinson’s GBA-N370S mutation

Do QB. et al, (2024), npj Parkinson's Disease, 10

Early striatal hyperexcitability in an in vitro human striatal microcircuit model carrying the Parkinson’s GBA-N370S mutation

Do QB. et al, (2023)

What we can learn from iPSC-derived cellular models of Parkinson's disease

(2020), 3 - 25

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons

Zambon F. et al, (2019), Human Molecular Genetics, 28, 2001 - 2013

Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes

Lang C. et al, (2019), Cell Stem Cell, 24, 93 - 106.e6

Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson’s disease

Sandor C. et al, (2017), Human Molecular Genetics, ddw412 - ddw412

ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons

Fernandes HJR. et al, (2016), Stem Cell Reports, 6, 342 - 356

αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson’s Disease?

Protter D. et al, (2012), Parkinson's Disease, 2012, 1 - 12